Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions

NCT00814346 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Cognitive Impairment

Interventions

DRUG: EGb761®
DRUG: Placebo

Sponsor

Ipsen